Merck CEO puts himself in diversification-is-good camp

Pfizer's slimming down by hiving off pieces of the company. Abbott Laboratories is preparing to spin off its pharma business completely. But Merck ($MRK) CEO Ken Frazier is having none of that. "My ph…
Read the full story: News